High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activity

It is assumed that an effective human immunodeficiency virus type 1 (HIV-1) vaccine should be capable of eliciting neutralizing antibodies. However, even the best antibodies known to date lack neutralizing ability against a significant proportion of primary HIV-1 variants and, despite great efforts,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: van Gils, Marit J., Edo-Matas, Diana, Schweighardt, Becky, Wrin, Terri, Schuitemaker, Hanneke
Médium: Artigo
Jazyk:Inglês
Vydáno: Society for General Microbiology 2010
Témata:
Animal
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2887566/
https://ncbi.nlm.nih.gov/pubmed/19793903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/vir.0.015693-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky